For the submission of applications for drugs defined in Section 2.(7) of Part I of the Notification from the Pharmaceutical and Food Safety Bureau, MHLW (PFSB Notification No. 0304004 dated March 4, 2009),  referred to as “follow-on biologics”, applicants should generate and collect data for submission in accordance with this Guideline.